Skip to content

Clinical trials

Terminated Breast Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Netherlands Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20061
20072
20081
20101
20111
20124
20143
20152
20162
20173
20182
20202
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Netherlands Cancer Institute6
Maastricht University Medical Center4
European Organisation for Research and Treatment of Cancer - EORTC2
Novartis Pharmaceuticals2
Allarity Therapeutics1
Amgen1
AstraZeneca1
Bayer1
CytomX Therapeutics1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms30
Neoplasm Metastasis5
Ovarian Neoplasms3
Carcinoma, Non-Small-Cell Lung1
Cardiotoxicity1
Chronic Pain1
Endometrial Neoplasms1
Head and Neck Neoplasms1
Hereditary Sensory and Autonomic Neuropathies1
Inflammatory Breast Neoplasms1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.